Cargando…

TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells

Transient receptor potential melastatin‐4 channel (TRPM4) dysregulation contributes to heart conditions, immune diseases, and cervical and prostate cancer. Up to now, the involvement of TRPM4 in colorectal cancer (CRC) pathophysiology remains unknown. Here, we investigated tumor tissue microarrays f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kappel, Sven, Stokłosa, Paulina, Hauert, Barbara, Ross‐Kaschitza, Daniela, Borgström, Anna, Baur, Roland, Galván, José A., Zlobec, Inti, Peinelt, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822246/ https://www.ncbi.nlm.nih.gov/pubmed/31441200 http://dx.doi.org/10.1002/1878-0261.12566

Ejemplares similares

Investigation of Novel Small Molecular TRPM4 Inhibitors in Colorectal Cancer Cells
por: Stokłosa, Paulina, et al.
Publicado: (2021)

A Novel Role of the TRPM4 Ion Channel in Exocytosis
por: Stokłosa, Paulina, et al.
Publicado: (2022)

TRPM4 in Cancer—A New Potential Drug Target
por: Borgström, Anna, et al.
Publicado: (2021)

TRP Channels in Digestive Tract Cancers
por: Stokłosa, Paulina, et al.
Publicado: (2020)

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010)

Identification of potent and selective small molecule inhibitors of the cation channel TRPM4
por: Ozhathil, Lijo Cherian, et al.
Publicado: (2018)

Cell Line Derived Xenograft Mouse Models Are a Suitable in vivo Model for Studying Tumor Budding in Colorectal Cancer
por: Georges, Laurent M. C., et al.
Publicado: (2019)

Refining the ITBCC tumor budding scoring system with a “zero-budding” category in colorectal cancer
por: Zlobec, Inti, et al.
Publicado: (2021)

Correction to: Store-Operated Ca(2+) Entry as a Prostate Cancer Biomarker — a Riddle with Perspectives
por: Kappel, Sven, et al.
Publicado: (2018)

Store-Operated Ca(2+) Entry as a Prostate Cancer Biomarker — a Riddle with Perspectives
por: Kappel, Sven, et al.
Publicado: (2017)

Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
por: Blank, Annika, et al.
Publicado: (2019)

Tumour budding: a promising parameter in colorectal cancer
por: Lugli, A, et al.
Publicado: (2012)

The battle for prognosis at the invasive front of colorectal cancer
por: Lugli, Alessandro, et al.
Publicado: (2020)

The Number and Position of Orai3 Units within Heteromeric Store-Operated Ca(2+) Channels Alter the Pharmacology of I(CRAC)
por: Kappel, Sven, et al.
Publicado: (2020)

Contribution of the α5 nAChR Subunit and α5SNP to Nicotine-Induced Proliferation and Migration of Human Cancer Cells
por: Papapostolou, Irida, et al.
Publicado: (2023)

Tumour budding and its clinical implications in gastrointestinal cancers
por: Zlobec, Inti, et al.
Publicado: (2020)

Tumor Budding in Upper Gastrointestinal Carcinomas
por: Koelzer, Viktor H., et al.
Publicado: (2014)

Cytokeratin‐based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience
por: Koelzer, Viktor H, et al.
Publicado: (2017)

Regulation of Ca(2+) signaling in prostate cancer cells
por: Kilch, Tatiana, et al.
Publicado: (2016)

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
por: Galván, José A., et al.
Publicado: (2014)

Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer
por: Bokhorst, John-Melle, et al.
Publicado: (2023)

Role of Intra- and Peritumoral Budding in the Interdisciplinary Management of Rectal Cancer Patients
por: Zlobec, Inti, et al.
Publicado: (2012)

Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer
por: Sokol, Lena, et al.
Publicado: (2015)

Targeting CRAC channels in inflammatory bowel disease
por: Kappel, Sven, et al.
Publicado: (2022)

Species-Specific Effects of Cation Channel TRPM4 Small-Molecule Inhibitors
por: Arullampalam, Prakash, et al.
Publicado: (2021)

Improving tumor budding reporting in colorectal cancer: a Delphi consensus study
por: Haddad, Tariq Sami, et al.
Publicado: (2021)

Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
por: Eppenberger, Manuela, et al.
Publicado: (2010)

Stratification and Prognostic Relevance of Jass’s Molecular Classification of Colorectal Cancer
por: Zlobec, Inti, et al.
Publicado: (2012)

Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing
por: Bihl, Michel P, et al.
Publicado: (2012)

High tumor budding stratifies breast cancer with metastatic properties
por: Salhia, Bodour, et al.
Publicado: (2015)

Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data
por: Trinh, Anne, et al.
Publicado: (2018)

CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival
por: Koelzer, Viktor H, et al.
Publicado: (2014)

Deletion of Trpm4 Alters the Function of the Na(v)1.5 Channel in Murine Cardiac Myocytes
por: Ozhathil, Lijo Cherian, et al.
Publicado: (2021)

Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?
por: Blank, Annika, et al.
Publicado: (2018)

Classification of colorectal tissue images from high throughput tissue microarrays by ensemble deep learning methods
por: Nguyen, Huu-Giao, et al.
Publicado: (2021)

Tissue Microarray Technology for Molecular Applications: Investigation of Cross-Contamination between Tissue Samples Obtained from the Same Punching Device
por: Vassella, Erik, et al.
Publicado: (2015)

Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
por: Märkl, Bruno, et al.
Publicado: (2016)

A Digital Pathology-Based Shotgun-Proteomics Approach to Biomarker Discovery in Colorectal Cancer
por: Zahnd, Stefan, et al.
Publicado: (2019)

Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1
por: Kandasamy, Palanivel, et al.
Publicado: (2021)

Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
por: Wartenberg, Martin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_784i9mureip0h251b6cs4cnud0